Korro Bio, Inc. (KRRO) vs OnKure Therapeutics, Inc. (OKUR)

A side-by-side comparison of Korro Bio, Inc. and OnKure Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KRRO vs OKUR

growth of $100 · dividends reinvested · last 5y
KRRO -98.1% (-54.9%/yr)OKUR -98.2% (-55.5%/yr)KRRO compounded faster over this window
020406080100Start $10020222023202420252026$2$2
KRRO OKUR

KRRO vs OKUR: by the numbers

  • •OKUR is the larger company ($100M vs $97M market cap).
  • •Both run net losses; OKUR's is the smaller (0.00% vs -4477.08% net margin).

Metrics side by side

Valuation

MetricKRROOKUR
P/S ratio40.78N/A
P/B ratio0.940.58

Profitability

MetricKRROOKUR
Gross margin33.04%0.00%
Operating margin-1366.43%0.00%
Net margin-4477.08%0.00%
ROE-103.31%-34.11%
ROIC-50.17%-35.98%

Growth (annualized)

MetricKRROOKUR
Revenue CAGR (5Y)-41.67%N/A
Total return CAGR (5Y)-50.72%-47.19%

Frequently asked

How have KRRO and OKUR total returns compared?
Over the past 5 years, KRRO delivered -50.72% and OKUR delivered -47.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.